Cargando…

Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV

BACKGROUND: Lopinavir is a specific reversible inhibitor of the enzyme HIV protease with mean oral bioavailability of less than 20% due to extensive hepatic metabolism by cytochrome P450 3A4. The reported half-life of Lopinavir is 5-6 hours and the maximum recommended daily dose is 400 mg/day. All t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Huda, Singh, Prabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416462/
https://www.ncbi.nlm.nih.gov/pubmed/30246641
http://dx.doi.org/10.2174/1570162X16666180924101650

Ejemplares similares